Skip to main content
Top
Published in: Tumor Biology 3/2011

01-06-2011 | Research Article

Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China

Authors: Miao-zhen Qiu, Zhi-qiang Wang, Dong-sheng Zhang, Hui-yan Luo, Zhi-wei Zhou, Feng-hua Wang, Yu-hong Li, Wen-qi Jiang, Rui-hua Xu

Published in: Tumor Biology | Issue 3/2011

Login to get access

Abstract

The incidence of gastric cancer in young has increased steadily in the last decades. Little is known about the clinicopathologic features and prognostic factors of young adult gastric cancer patients. The clinicopathological characteristics of 294 young adult gastric cancer patients between 20 and 50 years old were reviewed retrospectively from hospital records in Sun Yat-Sen University Cancer Center between 1996 and 2006. They were compared with 706 elder patients 51 years of age or over. A steady increasing in the proportion of female in the gastric carcinoma patients as the age decreasing was found. The distinguishing histological features of young adult patients were higher percentage of poorly differentiated grade and distant metastasis. The distribution of tumor–nodes–metastasis (TNM) stage was similar between these two groups. The 5-year disease-specific survival rate in the young adult group was significantly higher than in the elderly group. More patients receiving adjuvant chemotherapy were found in the young adult group. Multivariable analysis demonstrated that TNM stage and presence of angiolymphatic invasion were the independent negative predictors of survival for young patients with gastric cancer. Gastric cancer in young patients differs from that in elderly patients including a lack of male predilection, more aggressive histologic features, and better survival rate.
Literature
1.
go back to reference Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;10:2137–50.CrossRef Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;10:2137–50.CrossRef
2.
go back to reference Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, et al. Cancer epidemiology and control in North-Western and Central Asia—past, present and future. Asian Pac J Cancer Prev. 2010;11:17–32.PubMed Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, et al. Cancer epidemiology and control in North-Western and Central Asia—past, present and future. Asian Pac J Cancer Prev. 2010;11:17–32.PubMed
3.
go back to reference Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control. 1995;6:339–46.PubMedCrossRef Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control. 1995;6:339–46.PubMedCrossRef
4.
go back to reference Kitamura K, Yamaguchi T, Yamamoto K, Ichikawa D, Taniguchi H, Hagiwara A, et al. Clinicopathological analysis of gastric cancer in young adults. Hepatogastroenterology. 1996;43:1273–80.PubMed Kitamura K, Yamaguchi T, Yamamoto K, Ichikawa D, Taniguchi H, Hagiwara A, et al. Clinicopathological analysis of gastric cancer in young adults. Hepatogastroenterology. 1996;43:1273–80.PubMed
5.
go back to reference Semba S, Yokozaki H, Yasui W, Tahara E. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol. 1998;12:1245–51.PubMed Semba S, Yokozaki H, Yasui W, Tahara E. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol. 1998;12:1245–51.PubMed
6.
go back to reference Kitamura K, Taniguchi H, Yamaguchi T, Takahashi T. Early gastric cancer in young adults. Tohoku J Exp Med. 1996;179:93–100.PubMedCrossRef Kitamura K, Taniguchi H, Yamaguchi T, Takahashi T. Early gastric cancer in young adults. Tohoku J Exp Med. 1996;179:93–100.PubMedCrossRef
7.
go back to reference Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age and younger. Am J Surg. 1996;172:473–6.PubMedCrossRef Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age and younger. Am J Surg. 1996;172:473–6.PubMedCrossRef
8.
go back to reference Matley PJ, Dent DM, Madden MV, Price SK. Gastric carcinoma in young adults. Ann Surg. 1988;208:593–6.PubMedCrossRef Matley PJ, Dent DM, Madden MV, Price SK. Gastric carcinoma in young adults. Ann Surg. 1988;208:593–6.PubMedCrossRef
9.
go back to reference McNeer G. Cancer of the stomach in the young. Am J Roentgenol. 1941;41:537–50. McNeer G. Cancer of the stomach in the young. Am J Roentgenol. 1941;41:537–50.
10.
go back to reference Kath R, Fiehler J, Schneider CP, Höffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol. 2000;126:233–7.PubMedCrossRef Kath R, Fiehler J, Schneider CP, Höffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol. 2000;126:233–7.PubMedCrossRef
11.
go back to reference Hall TJ, Moulder J, Hsu HS, Achord J, Scott-Conner CE. Gastric carcinoma among younger individuals in Mississippi. South Med J. 1993;86:302–4.PubMedCrossRef Hall TJ, Moulder J, Hsu HS, Achord J, Scott-Conner CE. Gastric carcinoma among younger individuals in Mississippi. South Med J. 1993;86:302–4.PubMedCrossRef
12.
go back to reference Bloss RS, Miller TA, Copeland 3rd EM. Carcinoma of the stomach in the young adult. Surg Gynecol Obstet. 1980;150:883–6.PubMed Bloss RS, Miller TA, Copeland 3rd EM. Carcinoma of the stomach in the young adult. Surg Gynecol Obstet. 1980;150:883–6.PubMed
13.
14.
go back to reference Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol. 1996;26:139–43.PubMed Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol. 1996;26:139–43.PubMed
15.
go back to reference Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer. 1991;67:2401–6.PubMedCrossRef Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer. 1991;67:2401–6.PubMedCrossRef
16.
go back to reference Nishi K, Tokunaga A, Shimizu Y, Yoshiyuki T, Wada M, Matsukura N, et al. Immunohistochemical study of intracellular estradiol in human gastric cancer. Cancer. 1987;59:1328–32.PubMedCrossRef Nishi K, Tokunaga A, Shimizu Y, Yoshiyuki T, Wada M, Matsukura N, et al. Immunohistochemical study of intracellular estradiol in human gastric cancer. Cancer. 1987;59:1328–32.PubMedCrossRef
17.
go back to reference Mori M, Sugimachi K, Ohiwa T, Okamura T, Tamura S, Inokuchi K. Early gastric carcinoma in Japanese patients under 30 years of age. Br J Surg. 1985;72:289–91.PubMedCrossRef Mori M, Sugimachi K, Ohiwa T, Okamura T, Tamura S, Inokuchi K. Early gastric carcinoma in Japanese patients under 30 years of age. Br J Surg. 1985;72:289–91.PubMedCrossRef
18.
go back to reference Tso PL, Bringaze 3rd WL, Dauterive AH, Correa P, Cohn Jr I. Gastric carcinoma in the young. Cancer. 1987;59:1362–5.PubMedCrossRef Tso PL, Bringaze 3rd WL, Dauterive AH, Correa P, Cohn Jr I. Gastric carcinoma in the young. Cancer. 1987;59:1362–5.PubMedCrossRef
19.
go back to reference Miller AB. Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer. 1982;50:2533–40.PubMed Miller AB. Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer. 1982;50:2533–40.PubMed
20.
go back to reference Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36:1063–8.PubMedCrossRef Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36:1063–8.PubMedCrossRef
21.
go back to reference Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19–9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24:258–64.PubMed Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19–9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24:258–64.PubMed
22.
go back to reference Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88:21–7.PubMed Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88:21–7.PubMed
23.
go back to reference Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26–33.PubMedCrossRef Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26–33.PubMedCrossRef
24.
go back to reference Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–7.PubMedCrossRef Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–7.PubMedCrossRef
25.
go back to reference Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35. discussion 835–837.PubMed Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35. discussion 835–837.PubMed
26.
go back to reference Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766–72.PubMedCrossRef Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766–72.PubMedCrossRef
Metadata
Title
Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China
Authors
Miao-zhen Qiu
Zhi-qiang Wang
Dong-sheng Zhang
Hui-yan Luo
Zhi-wei Zhou
Feng-hua Wang
Yu-hong Li
Wen-qi Jiang
Rui-hua Xu
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2011
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-010-0145-2

Other articles of this Issue 3/2011

Tumor Biology 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine